Putnam Investments LLC increased its holdings in Evolent Health, Inc. (NYSE:EVH – Free Report) by 84.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 304,731 shares of the technology company’s stock after acquiring an additional 139,615 shares during the period. Putnam Investments LLC owned about 0.27% of Evolent Health worth $9,889,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. ICA Group Wealth Management LLC purchased a new stake in shares of Evolent Health during the 4th quarter worth about $32,000. Strs Ohio purchased a new stake in shares of Evolent Health during the 1st quarter worth about $51,000. Van ECK Associates Corp purchased a new stake in shares of Evolent Health during the 4th quarter worth about $54,000. Captrust Financial Advisors raised its stake in shares of Evolent Health by 254.4% during the 2nd quarter. Captrust Financial Advisors now owns 1,758 shares of the technology company’s stock worth $54,000 after purchasing an additional 1,262 shares in the last quarter. Finally, Clear Street Markets LLC purchased a new stake in shares of Evolent Health during the 4th quarter worth about $77,000.
Insider Buying and Selling at Evolent Health
In other Evolent Health news, CEO Seth Blackley sold 33,011 shares of the firm’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $30.78, for a total value of $1,016,078.58. Following the sale, the chief executive officer now owns 783,011 shares of the company’s stock, valued at approximately $24,101,078.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.30% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Analysis on EVH
Evolent Health Stock Performance
Shares of NYSE EVH opened at $26.20 on Friday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of -37.43 and a beta of 1.52. The business’s 50-day simple moving average is $27.85 and its 200-day simple moving average is $30.61. Evolent Health, Inc. has a 52 week low of $21.83 and a 52 week high of $38.67.
Evolent Health (NYSE:EVH – Get Free Report) last released its earnings results on Wednesday, August 2nd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.07. The firm had revenue of $469.14 million for the quarter, compared to analyst estimates of $462.51 million. Evolent Health had a positive return on equity of 8.07% and a negative net margin of 3.89%. As a group, equities research analysts expect that Evolent Health, Inc. will post 0.23 earnings per share for the current fiscal year.
Evolent Health Company Profile
Evolent Health, Inc, a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.
Featured Stories
- Five stocks we like better than Evolent Health
- Large Cap Stock Definition and How to Invest
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Reasons Price Weakness Is a Buying Opportunity For Lennar
- What is an Earnings Surprise?
- Name A Better Trio Than These Underrated High Potential Stocks
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.
